Vitenskapelig artikkel

• Stefansson, Ingunn Marie; Knutsvik, Gøril; Arnes, Jarle Birger et al. (2025). Loss of androgen receptor expression is associated with aggressive tumor features and reduced survival in breast cancer patients. (ekstern lenke)
• Sæle, Anna Kristine Myrmel; Svanøe, Amalie Abrahamsen; Askeland, Cecilie et al. (2025). Reduced GATA3 expression associates with immuno-metabolic alterations and aggressive features in breast cancer. (ekstern lenke)
• Ingebriktsen, Lise Martine; Svanøe, Amalie Abrahamsen; Sæle, Anna Kristine Myrmel et al. (2024). Age-Related Clusters and Favorable Immune Phenotypes in Breast Cancer of the Young Patients. (ekstern lenke)
• Torkildsen, Cecilie Fredvik; Austdal, Marie; Jarmund, Anders Hagen et al. (2024). New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients. (ekstern lenke)
• Lokøy, Ingvild Kathrin; Bakken, Inga Sofie; Wik, Elisabeth et al. (2024). Brystkreft hos menn – histopatologi og biomarkører. (ekstern lenke)
• Ingebriktsen, Lise Martine; Humlevik, Rasmus Olai Collett; Svanøe, Amalie Abrahamsen et al. (2024). Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features. (ekstern lenke)
• Svanøe, Amalie Abrahamsen; Humlevik, Rasmus Olai Collett; Knutsvik, Gøril et al. (2024). Age-related phenotypes in breast cancer: A population-based study. (ekstern lenke)
• Torkildsen, Cecilie Fredvik; Thomsen, Liv Cecilie Vestrheim; Sande, Ragnar et al. (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. (ekstern lenke)
• Vermorgen, Sanne; Gelton, Thijs; Bult, Peter et al. (2023). Endometrial Pipelle Biopsy Computer-Aided Diagnosis: A Feasibility Study. (ekstern lenke)
• Wik, Elisabeth; Aziz, Sura Mohammed; Vethe, Heidrun et al. (2022). Neurogenesis and angiogenesis are associated features of aggressive breast cancer. (ekstern lenke)
• Dybvik, Julie Andrea; Fasmer, Kristine Eldevik; Ytre-Hauge, Sigmund et al. (2022). MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. (ekstern lenke)
• Krüger, Kristi; Silwal-Pandit, Laxmi; Wik, Elisabeth et al. (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. (ekstern lenke)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (ekstern lenke)
• Fonnes, Tina; Strand, Elin; Fasmer, Kristine Eldevik et al. (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. (ekstern lenke)
• Askeland, Cecilie; Wik, Elisabeth; Finne, Kenneth et al. (2020). Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups. (ekstern lenke)
• Bischof, Katharina; Knappskog, Stian; Hjelle, Sigrun Margrethe et al. (2019). Influence of p53 isoform expression on survival in high-grade serous ovarian cancers. (ekstern lenke)
• Bischof, Katharina; Knappskog, Stian; Stefansson, Ingunn et al. (2018). High expression of the p53 isoform ? is associated with reduced progression-free survival in uterine serous carcinoma. (ekstern lenke)
• Raspotnig, Margrethe; Haugen, Mette; Thorsteinsdottir, Maria et al. (2017). Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies. (ekstern lenke)
• Halle, Mari Kyllesø; Tangen, Ingvild Løberg; Berg, Hege Fredriksen et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (ekstern lenke)
• Berg, Anna; Gulati, Ankush; Ytre-Hauge, Sigmund et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (ekstern lenke)
• Visser, Nicole C.M.; Werner, Henrica Maria Johanna; Krakstad, Camilla et al. (2017). Type of vascular invasion in association with progress of endometrial cancer. (ekstern lenke)
• Ytre-Hauge, Sigmund; Esmaeili, Morteza; Sjøbakk, Torill Eidhammer et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (ekstern lenke)
• Krüger, Kristi; Wik, Elisabeth; Knutsvik, Gøril et al. (2017). Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer. (ekstern lenke)
• Gibson, William J.; Høivik, Erling Andre; Halle, Mari Kyllesø et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (ekstern lenke)
• Knutsvik, Gøril; Collett, Karin; Arnes, Jarle et al. (2016). QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas. (ekstern lenke)
• Mauland, Karen Klepsland; Wik, Elisabeth; Høivik, Erling Andre et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (ekstern lenke)
• Klingen, Tor Audun; Chen, Ying; Stefansson, Ingunn et al. (2016). Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. (ekstern lenke)
• Ytre-Hauge, Sigmund; Husby, Jenny Hild Aase; Magnussen, Inger Johanne et al. (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. (ekstern lenke)
• Stefansson, Ingunn; Ræder, Maria B; Wik, Elisabeth et al. (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. (ekstern lenke)
• Berg, Anna; Høivik, Erling Andre; Mjøs, Siv et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (ekstern lenke)
• Bredholt, Geir; Mannelqvist, Monica; Stefansson, Ingunn et al. (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. (ekstern lenke)
• Krakstad, Camilla; Tangen, Ingvild Løberg; Høivik, Erling Andre et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (ekstern lenke)
• Haldorsen, Ingfrid S.; Stefansson, Ingunn; Grüner, Renate et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (ekstern lenke)
• Knutsvik, Gøril; Stefansson, Ingunn; Aziz, Sura Mohammed et al. (2014). Evaluation of Ki67 expression across distinct categories of breast cancer specimens: A Population-based study of matched surgical specimens, core needle biopsies and tissue microarrays. (ekstern lenke)
• Mannelqvist, Monica; Wik, Elisabeth; Stefansson, Ingunn et al. (2014). An 18-Gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer. (ekstern lenke)
• Wik, Elisabeth; Trovik, Jone; Kusonmano, Kanthida et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (ekstern lenke)
• Engerud, Hilde Renate Haugen; Tangen, Ingvild Løberg; Berg, Ansgar et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (ekstern lenke)
• Klingen, Tor Audun; Chen, Ying; Suhrke, Pål et al. (2013). Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas. (ekstern lenke)
• Haldorsen, Ingfrid S.; Grüner, Renate; Husby, Jenny Hild Aase et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (ekstern lenke)
• Wik, Elisabeth; Birkeland, Even; Trovik, Jone et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (ekstern lenke)
• Wik, Elisabeth; Ræder, Maria B; Krakstad, Camilla et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Werner, Henrica Maria Johanna et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (ekstern lenke)
• Ræder, Maria B; Birkeland, Even; Trovik, Jone et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (ekstern lenke)
• Krakstad, Camilla; Trovik, Jone; Wik, Elisabeth et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (ekstern lenke)
• Arnes, Jarle; Stefansson, Ingunn Marie; Straume, Oddbjørn et al. (2012). Vascular proliferation is a prognostic factor in breast cancer. (ekstern lenke)
• Krüger, Kristi; Stefansson, Ingunn Marie; Collett, Karin et al. (2012). Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. (ekstern lenke)
• Mannelqvist, Monica; Stefansson, Ingunn Marie; Wik, Elisabeth et al. (2012). Lipocalin 2 expression is associated with aggressive features of endometrial cancer. (ekstern lenke)
• Mannelqvist, Monica; Stefansson, Ingunn Marie; Bredholt, Geir et al. (2011). Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer. (ekstern lenke)
• Nalwoga, Hawa; Arnes, Jarle; Stefansson, Ingunn Marie et al. (2011). Vascular proliferation is increased in basal-like breast cancer. (ekstern lenke)
• Mauland, Karen Klepsland; Trovik, Jone; Wik, Elisabeth et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (ekstern lenke)
• Vandenput, Ingrid; Trovik, Jone; Leunen, Karin et al. (2011). Evolution in endometrial cancer evidence from an immunohistochemical study. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2011). Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer. (ekstern lenke)
• Gjerdrum, Christine; Tiron, Crina Elena; Høiby, Torill et al. (2010). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. (ekstern lenke)
• Bhriain, Hannah Ni; Trovik, Jone; Wik, Elisabeth et al. (2009). Plasma calprotectin concentrations in women with endometrial carcinoma. (ekstern lenke)
• Wik, Elisabeth; Trovik, Jone; Iversen, Ole-Erik et al. (2009). Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. (ekstern lenke)
• Mannelqvist, Monica; Stefansson, Ingunn Marie; Salvesen, Helga Birgitte et al. (2009). Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. (ekstern lenke)
• Salvesen, Helga Birgitte; Carter, Scott L.; Mannelqvist, Monica et al. (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (ekstern lenke)
• Dutt, Amit; Salvesen, Helga; Chent, Tzu-Hsiu et al. (2008). Drug-sensitive FGFR2 mutations in endometrial carcinoma. (ekstern lenke)
• Engelsen, Ingeborg Bøe; Mannelqvist, Monica; Stefansson, Ingunn Marie et al. (2008). Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. (ekstern lenke)
• Engelsen, Ingeborg Bøe; Stefansson, Ingunn Marie; Beroukhim, Rameen et al. (2008). HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas. (ekstern lenke)
• Collett, Karin; Eide, Geir Egil; Arnes, Jarle et al. (2006). Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. (ekstern lenke)
• Engelsen, Ingeborg; Stefansson, Ingunn Marie; Akslen, Lars A. et al. (2006). Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. (ekstern lenke)
• Bachmann, Ingeborg Margrethe; Halvorsen, Ole Johan; Collett, Karin et al. (2006). EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2006). Vascular proliferation is important for clinical progress of endometrial cancer. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2006). Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients. (ekstern lenke)
• Salvesen, Helga; Kumar, Rajiv; Stefansson, Ingunn Marie et al. (2005). Low frequency of BRAF and CDKN2A mutations in endometrial cancer. (ekstern lenke)
• Collett, Karin; Stefansson, Ingunn Marie; Eide, Johan et al. (2005). A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2004). Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2004). Prognostic impact of histological grade and vascular invasion compared with tumor cell proliferation in endometrial carcinoma of endometrioid type. (ekstern lenke)
• Foulkes, WD; Brunet, JS; Stefansson, Ingunn Marie et al. (2004). The prognostic implication of the basal-like (cyclin E-high/p27(low)/p53(+)/glomeruloid-microvascular-proliferation(+)) phenotype of BRCA1-related breast cancer. (ekstern lenke)
• Macdonald, ND; Salvesen, Helga; Ryan, A et al. (2004). Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series. (ekstern lenke)
• Salvesen, Helga; Stefansson, Ingunn Marie; Kretzschmar, EI et al. (2004). Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression. (ekstern lenke)
• Foulkes, WD; Stefansson, Ingunn Marie; Chappuis, PO et al. (2003). Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. (ekstern lenke)
• Salvesen, Helga B.; Gulluoglu, Mine G; Stefansson, Ingunn Marie et al. (2003). Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. (ekstern lenke)
• Stefansson, Ingunn Marie; Akslen, Lars A.; MacDonald, N et al. (2002). Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. (ekstern lenke)
• Salvesen, Helga B.; Stefansson, Ingunn Marie; Kalvenes, May Britt et al. (2002). Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. (ekstern lenke)

Errata

• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (ekstern lenke)

Leserinnlegg

• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2010). Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. (ekstern lenke)

Poster

• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (ekstern lenke)
• Mannelqvist, Monica; Bø, Trond Hellem; Bredholt, Geir et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (ekstern lenke)
• Mannelqvist, Monica; Bø, Trond Hellem; Bredholt, Geir et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (ekstern lenke)
• Salvesen, Helga; Bø, Trond Hellem; Stefansson, Ingunn Marie et al. (2006). Gene expression profiles identify an aggressive phenotype in endometrial carcinoma. (ekstern lenke)

Doktorgradsavhandling

• Stefansson, Ingunn Marie (2005). Biologic and prognostic markers of endometrial carcinoma. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin